We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+15.22%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$148M
(+14%)
Cap. Flow
+$27M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
38.39%
Holding
516
New
39
Increased
143
Reduced
266
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.89M |
| 2 |
Alibaba
BABA
|
+$4.05M |
| 3 |
iShares Silver Trust
SLV
|
+$4M |
| 4 |
Futu Holdings
FUTU
|
+$3.28M |
| 5 |
Broadcom
AVGO
|
+$3.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAP
SAP
|
+$2.28M |
| 2 |
Tapestry
TPR
|
+$2.13M |
| 3 |
Abbott
ABT
|
+$2.05M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$2.05M |
| 5 |
T-Mobile US
TMUS
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.61% |
| 2 | Healthcare | 20.82% |
| 3 | Communication Services | 12.95% |
| 4 | Consumer Discretionary | 11.61% |
| 5 | Consumer Staples | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TERN
376
DELISTED
Terns Pharmaceuticals
TERN
| $115K | 0.01% |
15,339
-2,202
| -13% | -$14.1K |
|
377
SIGA Technologies
SIGA
$206M
| $115K | 0.01% |
12,551
-1,798
| -13% | -$14.4K |
|
378
Keros Therapeutics
KROS
$222M
| $113K | 0.01% |
7,119
-1,038
| -13% | -$15.3K |
|
379
Transmedics
TMDX
$3.02B
| $112K | 0.01% |
+1,000
| New | +$117K |
|
380
Arvinas
ARVN
$580M
| $110K | 0.01% |
12,869
-1,791
| -12% | -$13.6K |
|
381
Erasca
ERAS
$6.45B
| $108K | 0.01% |
49,723
-7,174
| -13% | -$11.4K |
|
382
Savara
SVRA
$1.17B
| $108K | 0.01% |
30,296
-4,418
| -13% | -$13.1K |
|
|
TECX
383
Tectonic Therapeutic
TECX
$720M
| $108K | 0.01% |
6,880
+3,130
| +83% | +$64.6K |
|
384
Annexon
ANNX
$873M
| $108K | 0.01% |
35,261
+13,225
| +60% | +$32.8K |
|
|
KALV
385
DELISTED
KalVista Pharmaceuticals
KALV
| $107K | 0.01% |
8,824
-1,161
| -12% | -$16K |
|
386
Enanta Pharmaceuticals
ENTA
$393M
| $105K | 0.01% |
8,747
+4,454
| +104% | +$35.6K |
|
387
Personalis
PSNL
$1.52B
| $101K | 0.01% |
15,544
-2,196
| -12% | -$12.5K |
|
388
Tandem Diabetes Care
TNDM
$1.63B
| $97.1K | 0.01% |
+8,000
| New | +$108K |
|
389
Corvus Pharmaceuticals
CRVS
$1.27B
| $96.3K | 0.01% |
13,061
-2,427
| -16% | -$12.4K |
|
390
Rezolute
RZLT
$453M
| $94K | 0.01% |
+10,000
| New | +$66.6K |
|
|
ESPR
391
DELISTED
Esperion Therapeutics
ESPR
| $93.7K | 0.01% |
35,341
-4,467
| -11% | -$8.64K |
|
392
Zevra Therapeutics
ZVRA
$679M
| $93.6K | 0.01% |
9,840
-1,142
| -10% | -$11.5K |
|
|
CMPS
393
Compass Pathways
CMPS
$1.97B
| $92.1K | 0.01% |
16,076
-2,196
| -12% | -$9.87K |
|
394
Prothena Corp
PRTA
$475M
| $92.1K | 0.01% |
9,436
-1,375
| -13% | -$10.6K |
|
395
Omeros
OMER
$992M
| $89.9K | 0.01% |
21,929
+10,161
| +86% | +$40.3K |
|
396
Rigel Pharmaceuticals
RIGL
$782M
| $89.1K | 0.01% |
3,144
-446
| -12% | -$13.3K |
|
|
MBX
397
MBX Biosciences
MBX
$3.23B
| $87.5K | 0.01% |
+5,000
| New | +$66.9K |
|
|
LKFT
398
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $87K | 0.01% |
2,511
-465
| -16% | -$14.9K |
|
399
Lexicon Pharmaceuticals
LXRX
$1.05B
| $86K | 0.01% |
63,698
-9,245
| -13% | -$10.5K |
|
400
HUTCHMED
HCM
$2.13B
| $85.6K | 0.01% |
5,437
-793
| -13% | -$13.1K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2025 Portfolio in Review
As of Q3 2025, China Universal Asset Management Company held 516 positions worth $1.21B, up 14% from $1.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
China Universal Asset Management Company's Q3 2025 filing shows 39 new, 143 increased, 266 reduced and 39 closed positions. Its largest new stake was Alibaba: 30,923 shares worth $5.53M. The largest sale was SAP, an estimated $2.28M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.
- China Universal Asset Management Company's largest Q3 2025 buy was Alibaba: 30,923 shares worth $5.53M.
- China Universal Asset Management Company added most to NVIDIA in Q3 2025, an estimated $6.89M increase.
- China Universal Asset Management Company's biggest Q3 2025 reduction was SAP, cutting an estimated $2.28M.
- China Universal Asset Management Company fully exited Tapestry in Q3 2025, selling an estimated $2.13M.
- China Universal Asset Management Company's ten largest holdings make up 38% of its $1.21B portfolio in Q3 2025.
- China Universal Asset Management Company opened 39 new positions and closed 39 in Q3 2025.
- China Universal Asset Management Company's portfolio value rose 14% quarter-over-quarter to $1.21B.
Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.